MA40312A - Composition pharmaceutique orale d'isotrétinoïne - Google Patents

Composition pharmaceutique orale d'isotrétinoïne

Info

Publication number
MA40312A
MA40312A MA040312A MA40312A MA40312A MA 40312 A MA40312 A MA 40312A MA 040312 A MA040312 A MA 040312A MA 40312 A MA40312 A MA 40312A MA 40312 A MA40312 A MA 40312A
Authority
MA
Morocco
Prior art keywords
pharmaceutical composition
oral pharmaceutical
isotretinoin
present
preparing
Prior art date
Application number
MA040312A
Other languages
English (en)
Inventor
Anuj Kumar Fanda
Satish Kumar Jain
Rajesh Rao
Romi Barat Singh
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Publication of MA40312A publication Critical patent/MA40312A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition pharmaceutique orale d'isotrétinoïne présentant une biodisponibilité accrue. L'invention concerne également un procédé de préparation de la composition pharmaceutique orale selon l'invention.
MA040312A 2014-05-29 2015-05-29 Composition pharmaceutique orale d'isotrétinoïne MA40312A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1422DE2014 2014-05-29
IN1736DE2014 2014-06-30
IN3488DE2014 2014-12-01

Publications (1)

Publication Number Publication Date
MA40312A true MA40312A (fr) 2017-04-05

Family

ID=54699996

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040312A MA40312A (fr) 2014-05-29 2015-05-29 Composition pharmaceutique orale d'isotrétinoïne

Country Status (10)

Country Link
US (2) US9999606B2 (fr)
EP (1) EP3148644A4 (fr)
JP (1) JP2017516792A (fr)
AU (1) AU2015265454A1 (fr)
BR (1) BR112016028083A2 (fr)
CA (1) CA2950531A1 (fr)
MA (1) MA40312A (fr)
MX (1) MX2016015465A (fr)
RU (1) RU2016150863A (fr)
WO (1) WO2015181802A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015294993A1 (en) * 2014-07-31 2017-02-16 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition of isotretinoin
US10517846B2 (en) 2016-05-26 2019-12-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for treating acne
SG11201912887VA (en) * 2017-06-29 2020-01-30 Skyline Biosciences Llc Isotretinoin oral-mucosal formulations and methods for using same
US10716774B1 (en) 2018-01-05 2020-07-21 Yale Pharmaceuticals LLC Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability
KR20250054055A (ko) 2022-07-01 2025-04-22 아크로테크 바이오파마 인코포레이티드. 이소트레티노인을 포함하는 제약 조성물 및 그의 제조 방법 및 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ES2225600T3 (es) 2000-09-22 2005-03-16 Galephar M/F Composicion semi-solida de isotretinoina.
JP4061015B2 (ja) * 2000-10-30 2008-03-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 レチノイン酸レセプターアゴニスト作用を有する薬剤含有組成物
BR0117191A (pt) * 2001-12-06 2005-05-10 Ranbaxy Lab Ltd Composições nanoparticuladas de isotretinoina
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
SE0303135D0 (sv) * 2003-11-25 2003-11-25 Lipocore Holding Ab Controlled food effect composition
CN1943567A (zh) * 2006-10-12 2007-04-11 华东理工大学 维a酸类药物的自微乳化组合物及其制备方法
SG176096A1 (en) * 2009-05-20 2011-12-29 Ranbaxy Lab Ltd Liquid dosage forms of isotretinoin
WO2012053013A2 (fr) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Compositions pharmaceutiques d'agents anti-acné
US9078925B2 (en) * 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
WO2014197640A1 (fr) * 2013-06-04 2014-12-11 South Dakota State University Nouvelles nanoparticules coeur-écorce pour administration orale de médicament

Also Published As

Publication number Publication date
RU2016150863A3 (fr) 2018-12-29
US9999606B2 (en) 2018-06-19
WO2015181802A3 (fr) 2016-03-03
EP3148644A4 (fr) 2017-12-20
CA2950531A1 (fr) 2015-12-03
JP2017516792A (ja) 2017-06-22
US20160089353A1 (en) 2016-03-31
MX2016015465A (es) 2017-03-27
BR112016028083A2 (pt) 2017-08-22
US20180193299A1 (en) 2018-07-12
AU2015265454A1 (en) 2016-12-15
EP3148644A2 (fr) 2017-04-05
RU2016150863A (ru) 2018-07-03
WO2015181802A2 (fr) 2015-12-03

Similar Documents

Publication Publication Date Title
IL252843A0 (en) A process for preparing a diarylthiohydantoin compound
IN2014CH00247A (fr)
ZA201604838B (en) Process for the production of synthesis gas
MX2016015464A (es) Composicion farmaceutica oral de isotretinoina.
IN2013MU00646A (fr)
MX2020009444A (es) Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.
HUE058627T2 (hu) Új eljárás nagy tisztaságú prosztaglandinok elõállítására
EP3182981A4 (fr) Procédé de production d'isomaltooligosaccharides
MX2016015465A (es) Composicion farmaceutica oral de isotretinoina.
MA40447A (fr) Composition pharmaceutique orale d'isotrétinoïne
PL3212391T3 (pl) Maszyna do wytwarzania rur tekturowych
ZA201801650B (en) Process for producing novel 4-benzoazonine derivatives
MX382631B (es) Proceso para la preparacion de derivados dihidroisoxazol.
PL3126111T3 (pl) Maszyna do produkcji produktów ceramicznych
GB2564185B (en) Process for the preparation of derivatives of benzodioxole
PT3394069T (pt) Processo para a preparação de inibidores de integrase de vih
PL3223799T3 (pl) Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer
MX380240B (es) Preparación de piperidin-4-carbotioamida.
IN2014CH00444A (fr)
IN2014MU01191A (fr)
IN2013MU01305A (fr)
TH1601000381A (th) สารประกอบอินโดไลซีนแบบใหม่, กระบวนการในการเตรียมสารประกอบดังกล่าว และองค์ประกอบทางเภสัชกรรมที่ประกอบด้วยสารประกอบดังกล่าว